168
Views
25
CrossRef citations to date
0
Altmetric
Theme: General - Review

Aging is a primary risk factor for cardiac arrhythmias: disruption of intracellular Ca2+ regulation as a key suspect

, &
Pages 1059-1067 | Published online: 10 Jan 2014

References

  • Crowe PA. Quotes on Living a Long Life : Mankind’s Wisdom on Aging from Diogenes to Dylan. First Edition. Richer Resources Publications, VA, USA (2006).
  • Fries JF. Aging, natural death, and the compression of morbidity. Bull. World Health Organ.80(3), 245–250 (2002).
  • Lakatta EG, Sollott SJ. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp. Biochem. Physiol. A Mol. Integr. Physiol.132(4), 699–721 (2002).
  • Goonasekara CL, Balse E, Hatem S, Steele DF, Fedida D. Cholesterol and cardiac arrhythmias. Expert Rev. Cardiovasc. Ther.8(7), 965–979 (2010).
  • Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation), developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation114(7), e257–e354 (2006).
  • Chamorro A. Dual antiplatelet therapy is not optimal for stroke prevention in patients with atrial fibrillation. Int. J. Stroke5(1), 28–29 (2010).
  • Hopps S, Marcy TR. Warfarin versus aspirin: using CHADS2 to guide therapy for stroke prevention in nonvalvular atrial fibrillation. Consult. Pharm.24(11), 841–844 (2009).
  • Lopshire JC, Zipes DP. Sudden cardiac death: better understanding of risks, mechanisms, and treatment. Circulation114(11), 1134–1136 (2006).
  • Verheijck EE, van Ginneken AC, Wilders R, Bouman LN. Contribution of L-type Ca2+ current to electrical activity in sinoatrial nodal myocytes of rabbits. Am. J. Physiol.276(3 Pt 2), H1064–H1077 (1999).
  • Lakatta EG, Maltsev VA, Bogdanov KY, Stern MD, Vinogradova TM. Cyclic variation of intracellular calcium: a critical factor for cardiac pacemaker cell dominance. Circ. Res.92(3), e45–e50 (2003).
  • Lakatta EG, Difrancesco D. What keeps us ticking: a funny current, a calcium clock, or both? J. Mol. Cell. Cardiol.47(2), 157–170 (2009).
  • Brown HF. Electrophysiology of the sinoatrial node. Physiol. Rev.62(2), 505–530 (1982).
  • Hartel G, Talvensaari T. Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients. Acta Med. Scand.198(5), 341–347 (1975).
  • Bers DM, Despa S. Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts. J. Pharmacol. Sci.100(5), 315–322 (2006).
  • Vassalle M, Lin CI. Calcium overload and cardiac function. J. Biomed. Sci.11(5), 542–565 (2004).
  • Podrid PJ, Kowey PR. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. Second Edition. Lippincott William & Wilkins, London, UK, 973 (2001).
  • Zipes DP. Mechanisms of clinical arrhythmias. Pacing Clin. Electrophysiol.26(8), 1778–1792 (2003).
  • Pumir A, Arutunyan A, Krinsky V, Sarvazyan N. Genesis of ectopic waves: role of coupling, automaticity, and heterogeneity. Biophys. J.89(4), 2332–2349 (2005).
  • Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell104(4), 569–580 (2001).
  • Marine JE, Korley VJ, Obioha-Ngwu O et al. Different patterns of interatrial conduction in clockwise and counterclockwise atrial flutter. Circulation104(10), 1153–1157 (2001).
  • Zeng J, Rudy Y. Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys. J.68(3), 949–964 (1995).
  • Ward C, Witham M. A Practical Guide to Heart Failure in Older People. Wiley-Blackwell, Oxford, UK, xiv, 280 (2009).
  • Wang TJ, Larson MG, Levy D et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation107(23), 2920–2925 (2003).
  • Aronow WS, Ahn C, Mercando AD, Epstein S, Kronzon I. Prevalence and association of ventricular tachycardia and complex ventricular arrhythmias with new coronary events in older men and women with and without cardiovascular disease. J. Gerontol. A Biol. Sci. Med. Sci.57(3), M178–M180 (2002).
  • Marín-García J. Aging and the Heart: A Post-Genomic View. Springer, NY, USA (2010).
  • Wang Q, Curran ME, Splawski I et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet.12(1), 17–23 (1996).
  • Walker KE, Lakatta EG, Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc. Res.27(11), 1968–1977 (1993).
  • Bers DM. Cardiac excitation–contraction coupling. Nature415(6868), 198–205 (2002).
  • Soeller C, Cannell MB. Examination of the transverse tubular system in living cardiac rat myocytes by 2-photon microscopy and digital image-processing techniques. Circ. Res.84(3), 266–275 (1999).
  • D’Agnolo A, Luciani GB, Mazzucco A, Gallucci V, Salviati G. Contractile properties and Ca2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy. Circulation85(2), 518–525 (1992).
  • Gyorke S, Stevens SC, Terentyev D. Cardiac calsequestrin: quest inside the SR. J. Physiol.587(Pt 13), 3091–3094 (2009).
  • Bassani RA, Bers DM. Rate of diastolic Ca release from the sarcoplasmic reticulum of intact rabbit and rat ventricular myocytes. Biophys. J.68(5), 2015–2022 (1995).
  • Stewart PS, MacLennan DH. Surface particles of sarcoplasmic reticulum membranes. Structural features of the adenosine triphosphatase. J. Biol. Chem.249(3), 985–993 (1974).
  • Haghighi K, Gregory KN, Kranias EG. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy. Biochem. Biophys. Res. Commun.322(4), 1214–1222 (2004).
  • Toyofuku T, Kurzydlowski K, Tada M, MacLennan DH. Identification of regions in the Ca(2+)-ATPase of sarcoplasmic reticulum that affect functional association with phospholamban. J. Biol. Chem.268(4), 2809–2815 (1993).
  • Sipido KR. Calcium overload, spontaneous calcium release, and ventricular arrhythmias. Heart Rhythm3(8), 977–979 (2006).
  • Pepe S. Mitochondrial function in ischaemia and reperfusion of the ageing heart. Clin. Exp. Pharmacol. Physiol.27(9), 745–750 (2000).
  • Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ. Res.68(6), 1560–1568 (1991).
  • Jones SA, Boyett MR, Lancaster MK. Declining into failure: the age-dependent loss of the L-type calcium channel within the sinoatrial node. Circulation115(10), 1183–1190 (2007).
  • Segawa I, Kikuchi M, Tashiro A, Hiramori K, Sato M, Satodate R. Association of myotonic dystrophy and sick sinus syndrome, with special reference to electrophysiological and histological examinations. Intern. Med.35(3), 185–188 (1996).
  • Jones SA, Boyett MR, Lancaster MK. Ageing-related changes of connexins and conduction within the sinoatrial node. J. Physiol.560(Pt 2), 429–437 (2004).
  • Wei JY, Spurgeon HA, Lakatta EG. Excitation-contraction in rat myocardium: alterations with adult aging. Am. J. Physiol.246(6 Pt 2), H784–H791 (1984).
  • Froehlich JP, Lakatta EG, Beard E, Spurgeon HA, Weisfeldt ML, Gerstenblith G. Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium. J. Mol. Cell. Cardiol.10(5), 427–438 (1978).
  • Lompré AM, Lambert F, Lakatta EG, Schwartz K. Expression of sarcoplasmic reticulum Ca(2+)-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ. Res.69(5), 1380–1388 (1991).
  • Wong K, Boheler KR, Bishop J, Petrou M, Yacoub MH. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc. Res.37(1), 115–122 (1998).
  • Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation81(2 Suppl.), III21–III32 (1990).
  • Fares E, Howlett SE. Effect of age on cardiac excitation–contraction coupling. Clin. Exp. Pharmacol. Physiol.37(1), 1–7 (2010).
  • Jones SA, Boyett MR, Lancaster MK. Declining into failure – the age-dependent loss of the L-type calcium channel within the sinoatrial node. Circulation115(10), 1183–1190 (2007).
  • Vinogradova TM. Sarcoplasmic reticulum Ca2+ pumping kinetics regulates timing of local Ca2+ releases and spontaneous beating rate of rabbit sinoatrial node pacemaker cells. Circ. Res.107(6), 767–775 (2010).
  • Volders PG, Vos MA, Szabo B. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc. Res.46(3), 376–392 (2000).
  • Furman S, Robinson G. The use of an intracardiac pacemaker in the correction of total heart block. Surg. Forum9, 245–248 (1958).
  • Wellens HJ, Schuilenburg RM, Durrer D. Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation46(2), 216–226 (1972).
  • Josephson ME, Harken AH, Horowitz LN. Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation60(7), 1430–1439 (1979).
  • Cox JL. Surgery for atrial fibrillation. Semin. Thorac. Cardiovasc. Surg.1(1), 67–73 (1989).
  • Mirowski M, Reid PR, Mower MM. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N. Engl. J. Med.303(6), 322–324 (1980).
  • Lee DS, Green LD, Liu PP et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J. Am. Coll. Cardiol.41(9), 1573–1582 (2003).
  • Lee MA, Morady F, Kadish A et al. Catheter modification of the atrioventricular junction with radiofrequency energy for control of atrioventricular nodal reentry tachycardia. Circulation83(3), 827–835 (1991).
  • Ambrosi CM, Ripplinger CM, Efimov IR, Fedorov VV. Termination of sustained atrial flutter and fibrillation using low-voltage multiple-shock therapy. Heart Rhythm8(1), 101–108 (2011).
  • Roden DM. Antiarrhythmic drugs: past, present and future. J. Cardiovasc. Electrophysiol.14(12), 1389–1396 (2003).
  • Fogoros RN. Antiarrhythmic Drugs: A Practical Guide. Second Edition. Blackwell Futura, Oxford, UK, viii, 183 (2007).
  • Roden DM. Drug-induced prolongation of the QT interval. N. Engl. J. Med.350(10), 1013–1022 (2004).
  • Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N. Engl. J. Med.324(12), 781–788 (1991).
  • Wellens HJ. Cardiac arrhythmias: the quest for a cure: a historical perspective. J. Am. Coll. Cardiol.44(6), 1155–1163 (2004).
  • Wang J, Liu L, Feng J, Nattel S. Regional and functional factors determining induction and maintenance of atrial fibrillation in dogs. Am. J. Physiol.271(1 Pt 2), H148–H158 (1996).
  • Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med.347(23), 1825–1833 (2002).
  • Yang JH, Saucerman JJ. Computational models reduce complexity and accelerate insight into cardiac signaling networks. Circ. Res.108(1), 85–97 (2011).
  • Olivetti G, Giordano G, Corradi D et al. Gender differences and aging: effects on the human heart. J. Am. Coll. Cardiol.26(4), 1068–1079 (1995).
  • Ashcroft GS, Mills SJ, Ashworth JJ. Ageing and wound healing. Biogerontology3(6), 337–345 (2002).
  • Josephson IR, Guia A, Stern MD, Lakatta EG. Alterations in properties of L-type Ca channels in aging rat heart. J. Mol. Cell. Cardiol.34(3), 297–308 (2002).
  • Yanni J, Tellez JO, Sutyagin PV, Boyett MR, Dobrzynski H. Structural remodelling of the sinoatrial node in obese old rats. J. Mol. Cell. Cardiol.48(4), 653–662 (2010).
  • Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation107(2), 346–354 (2003).
  • Docherty JR. Cardiovascular responses in ageing: a review. Pharmacol. Rev.42(2), 103–125 (1990).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.